entity

NfL elevation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NfL elevation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections

2Hypotheses

3Analyses

1Outgoing

2Incoming

0Experiments

4Debates

No AI portrait yet

Outgoing (1)

Target	Relation	Type	Str
Conversion to MCI	correlates_with	phenotype	0.70

Incoming (2)

Source	Relation	Type	Str
AQP4-IgG seropositive NMOSD	associated_with	biomarker	0.70
IL-1β	associated_with	biomarker	0.70

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Plasma NfL Elevation Secondary to BBB-Associated Transport D	0.940	-	What blood-brain barrier permeability ch
Plasma NfL Elevation Secondary to BBB-Associated Transport D	0.485	-	What blood-brain barrier permeability ch

Mentioning Analyses (3)

Scientific analyses that reference this entity

Neuroinflammation Biomarker Panel for Early AD Detection

neurodegeneration | 2026-04-18 | 7 hypotheses Top: 0.105

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.579

What are the specific molecular mechanisms by which AQP4 dysfunction contributes

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.690

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (4)

Multi-agent debates referencing this entity

The abstract states that AQP4 'is part of the pathogenesis' of CNS disorders and

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

What is the optimal blood-based biomarker panel combining established markers (G

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning NfL elevation in their description or question text

No additional research found